Table 1 Characteristics at baseline.

From: Effect of intravenous lidocaine on postoperative fatigue syndrome in patients undergoing laparoscopic radical colorectal cancer surgery: a randomized clinical trial

Characteristics

Group L (n = 40)

Group C (n = 40)

P value

Age (yr)

65.28 ± 8.80

60.63 ± 13.36

0.070

Sex (male)

26(65%)

24(60%)

0.644

BMI (kg·m− 2)

22.15 ± 1.64

22.39 ± 2.17

0.568

ASA physical status

  

0.725

 II

35(87.5%)

36(90%)

 

 III

5(12.5%)

4(10%)

 

Tumor TNM stage

  

0.484

 II

28(70%)

25(62.5%)

 

 III

12(30%)

15(37.5%)

 

Intraoperative information

 The dosage of propofol (mg)

173.75 ± 30.73

169.88 ± 35.33

0.602

 Duration of surgery (min)

1146.50 ± 207.62

1122.00 ± 228.48

0.617

 The dosage of remifentanil (µg)

2307.50 ± 424.84

2257.00 ± 463.62

0.613

 The dosage of cisatracurium besylate (mg)

15.80 ± 4.65

16.85 ± 5.21

0.345

 VAS 1 day before surgery

0.51 ± 0.45

0.54 ± 0.48

0.774

 Christensen score 1 day before surgery

1.79 ± 0.37

1.75 ± 0.41

0.691

  1. Data are expressed as mean ± SD, or n (%). BMI, body mass index. ASA, American Society of Anesthesiologists. VAS, visual analogue scale.
Back to article page